- Corporate Officers - L
- Lynch Karen S
Insider Trading History of Lynch Karen S
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lynch Karen S since 2006.
This trader's CIK number is 1333760.
At the time of last reporting, Lynch Karen S was the President and CEO of Cvs Health Corp. (stock ticker symbol CVS).
Also see all insider trading activities at Cvs Health Corp.
Note that in the past
Lynch Karen S also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cigna Corp (CI) by Lynch Karen S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | CI | 0 | $0 | 4,771 | $802,830 | 12,491 | $879,423 |
| 2006 | CI | 0 | $0 | 0 | $0 | 7,631 | $475,106 |
Yearly summary of insider trading at Cvs Health Corp (CVS) by Lynch Karen S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | CVS | 14,000 | $976,569 | 0 | $0 | 0 | $0 |
| 2019 | CVS | 0 | $0 | 80,143 | $6,010,725 | 0 | $0 |
Yearly summary of insider trading at Aetna Inc /pa/ (AET) by Lynch Karen S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | AET | 0 | $0 | 0 | $0 | 17,912 | $0 |
| 2017 | AET | 0 | $0 | 23,096 | $3,644,078 | 83,773 | $6,053,436 |
| 2016 | AET | 0 | $0 | 45,000 | $5,379,930 | 0 | $0 |
| 2015 | AET | 0 | $0 | 0 | $0 | 56,068 | $0 |
| 2014 | AET | 0 | $0 | 0 | $0 | 54,854 | $0 |
| 2013 | AET | 4,035 | $199,869 | 0 | $0 | 17,902 | $0 |
Yearly summary of insider trading at Magellan Health Inc (MGLN) by Lynch Karen S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | MGLN | 0 | $0 | 0 | $0 | 5,551 | $0 |
| 2011 | MGLN | 0 | $0 | 49,500 | $2,428,964 | 2,927 | $0 |
| 2010 | MGLN | 0 | $0 | 30,000 | $1,467,739 | 0 | $0 |
Insider trading activities at 4 companies by Lynch Karen S:
1. Cigna Corp (CI)
2. Cvs Health Corp (CVS)
3. Aetna Inc /pa/ (AET)
4. Magellan Health Inc (MGLN)
Table 1. Insider trading of Cigna Corp (CI) by Lynch Karen S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-06-01 | CI | Option Ex | 6,451 | 91.83 | 592,395 |
| 2007-06-01 | CI | Sale | 4,771 | 168.27 | 802,830 |
| 2007-03-16 | CI | Option Ex | 2,707 | 55.44 | 150,076 |
| 2007-02-16 | CI | Option Ex | 3,333 | 41.09 | 136,952 |
| 2006-03-02 | CI | Option Ex | 7,631 | 62.26 | 475,106 |
Table 2. Insider trading of Cvs Health Corp (CVS) by Lynch Karen S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-05-03 | CVS | Buy | 14,000 | 69.75 | 976,569 |
| 2019-11-18 | CVS | Sale | 80,143 | 75.00 | 6,010,725 |
Table 3. Insider trading of Aetna Inc /pa/ (AET) by Lynch Karen S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-03-02 | AET | Option Ex | 17,912 | .00 | 0 |
| 2017-09-18 | AET | Sale | 15,271 | 161.91 | 2,472,527 |
| 2017-09-12 | AET | Option Ex | 53,773 | 72.26 | 3,885,636 |
| 2017-06-07 | AET | Sale | 7,825 | 149.72 | 1,171,551 |
| 2017-06-02 | AET | Option Ex | 30,000 | 72.26 | 2,167,800 |
| 2016-11-11 | AET | Sale | 45,000 | 119.55 | 5,379,930 |
| 2015-07-23 | AET | Option Ex | 40,858 | .00 | 0 |
| 2015-02-02 | AET | Option Ex | 15,210 | .00 | 0 |
| 2014-07-23 | AET | Option Ex | 54,854 | .00 | 0 |
| 2013-07-23 | AET | Option Ex | 17,902 | .00 | 0 |
| 2013-02-06 | AET | Buy | 4,035 | 49.53 | 199,869 |
Table 4. Insider trading of Magellan Health Inc (MGLN) by Lynch Karen S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-03-03 | MGLN | Option Ex | 5,551 | .00 | 0 |
| 2011-09-02 | MGLN | Sale | 20,100 | 47.54 | 955,574 |
| 2011-09-01 | MGLN | Sale | 11,900 | 49.91 | 593,929 |
| 2011-04-26 | MGLN | Sale | 3,250 | 50.01 | 162,526 |
| 2011-04-27 | MGLN | Sale | 13,250 | 50.33 | 666,925 |
| 2011-04-08 | MGLN | Sale | 500 | 50.01 | 25,005 |
| 2011-04-08 | MGLN | Sale | 500 | 50.01 | 25,005 |
| 2011-03-03 | MGLN | Option Ex | 2,927 | .00 | 0 |
| 2010-11-10 | MGLN | Sale | 17,500 | 48.95 | 856,537 |
| 2010-11-09 | MGLN | Sale | 5,000 | 48.70 | 243,500 |
| 2010-11-08 | MGLN | Sale | 7,500 | 49.03 | 367,702 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Lynch Karen S
(President and CEO of Cvs Health Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.